Health Care & Life Sciences » Pharmaceuticals | Yungjin Pharm. Co. Ltd.

Yungjin Pharm. Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,742
909
3,386
4,202
1,868
6,101
Depreciation, Depletion & Amortization
4,895
4,914
5,863
5,830
6,602
6,642
Other Funds
42
3
-
-
-
6,566
Funds from Operations
13,662
10,626
14,500
15,225
13,846
7,107
Changes in Working Capital
8,836
5,022
6,528
12,870
11,193
6,044
Net Operating Cash Flow
4,826
5,605
7,972
2,355
2,653
1,063
Capital Expenditures
6,725
11,519
15,234
4,879
10,989
Sale of Fixed Assets & Businesses
50
15
311
3,593
40
Purchase/Sale of Investments
1,036
45
1,651
112
13,303
Net Investing Cash Flow
5,565
11,459
12,635
856
4,282
Issuance/Reduction of Debt, Net
4,574
1,453
8,046
4,361
4,417
Net Financing Cash Flow
4,616
1,456
8,046
4,361
4,417
Net Change in Cash
5,780
7,311
3,384
2,853
2,515
Free Cash Flow
1,805
5,698
5,781
2,339
7,940
Other Sources
13,363
-
636
1,058
1,934
Exchange Rate Effect
4
-
-
9
3
Other Uses
86
-
-
741
6

About Yungjin Pharm. Co.

View Profile
Address
13 Olympic-ro 35da-gil
Seoul SL 05510
Korea, Republic Of
Employees -
Website http://www.yungjin.co.kr
Updated 07/08/2019
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.